Metabotyping of Docosahexaenoic Acid - Treated Alzheimer’s Disease Cell Model

BACKGROUND: Despite the significant amount of work being carried out to investigate the therapeutic potential of docosahexaenoic acid (DHA) in Alzheimer’s disease (AD), the mechanism by which DHA affects amyloid-β precursor protein (AβPP)-induced metabolic changes has not been studied. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahety, Priti, Tan, Yee Min, Hong, Yanjun, Zhang, Luqi, Chan, Eric Chun Yong, Ee, Pui-Lai Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937442/
https://www.ncbi.nlm.nih.gov/pubmed/24587236
http://dx.doi.org/10.1371/journal.pone.0090123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937442/
https://www.ncbi.nlm.nih.gov/pubmed/24587236
http://dx.doi.org/10.1371/journal.pone.0090123

Ejemplares similares